|
End-of-day quote
NYSE
|
||
| - USD | - |
|
| 06/16/06 | Allergan : Obama's inversion curbs kill Pfizer's $160 billion Allergan deal | RE |
| 31/16/31 | Argus Media close to stake sale, Temasek among bidders - sources | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
Eric Boyer
IRC | Investor Relations Contact | - | 03/02/2014 |
Carlos Pascual
PRN | Corporate Officer/Principal | - | 12/01/2015 |
| Director | Title | Age | Since |
|---|---|---|---|
Daniel H. Yergin
BRD | Director/Board Member | 79 | 26/11/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.07% | +5.44% | -15.20% | +12.68% | 12TCr | |
| +1.35% | +4.99% | -2.81% | +47.06% | 8.15TCr | |
| +1.97% | +6.52% | -31.60% | -16.18% | 4.47TCr | |
| +0.51% | +2.84% | +3.85% | +9.21% | 4.13TCr | |
| +0.17% | +8.03% | -23.25% | -2.59% | 3.15TCr | |
| +0.21% | +11.48% | -29.80% | -36.28% | 1.92TCr | |
| +0.58% | +4.61% | -28.53% | -8.17% | 1.88TCr | |
| +1.06% | +3.32% | -36.03% | -18.64% | 1.73TCr | |
| +1.77% | +1.92% | +14.51% | +55.63% | 1.61TCr | |
| Average | +0.96% | +5.63% | -16.54% | +4.75% | 4.36TCr | |
| Weighted average by Cap. | +1.06% | +5.50% | -14.19% | +11.93% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
